DICHIARA, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 1.961
EU - Europa 1.372
AS - Asia 1.042
AF - Africa 211
SA - Sud America 160
OC - Oceania 7
Totale 4.753
Nazione #
US - Stati Uniti d'America 1.917
IT - Italia 679
SG - Singapore 537
CN - Cina 324
DE - Germania 217
CI - Costa d'Avorio 155
BR - Brasile 140
IE - Irlanda 133
FI - Finlandia 105
RU - Federazione Russa 74
KR - Corea 45
VN - Vietnam 45
CA - Canada 35
SN - Senegal 33
ES - Italia 30
GB - Regno Unito 30
UA - Ucraina 22
IN - India 16
FR - Francia 15
JP - Giappone 15
SE - Svezia 13
BD - Bangladesh 11
ID - Indonesia 11
NL - Olanda 11
PL - Polonia 10
CZ - Repubblica Ceca 9
AR - Argentina 8
HK - Hong Kong 8
ZA - Sudafrica 7
BJ - Benin 6
IQ - Iraq 6
TR - Turchia 6
BE - Belgio 5
MX - Messico 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
EC - Ecuador 4
GR - Grecia 4
MA - Marocco 4
UZ - Uzbekistan 4
AT - Austria 3
CH - Svizzera 3
CL - Cile 3
HU - Ungheria 3
IL - Israele 3
LT - Lituania 3
NZ - Nuova Zelanda 3
CO - Colombia 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
HN - Honduras 2
IR - Iran 2
PY - Paraguay 2
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
ME - Montenegro 1
NP - Nepal 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
TN - Tunisia 1
Totale 4.753
Città #
Dallas 369
Singapore 313
Chandler 295
Santa Clara 276
Munich 186
Catania 165
Abidjan 155
Chicago 142
Dublin 132
Ashburn 104
Hefei 81
Helsinki 79
Beijing 61
Civitanova Marche 60
Boardman 54
Seoul 45
Naples 38
Los Angeles 37
Cambridge 33
Dakar 33
Lawrence 33
Andover 31
Nanjing 28
Moscow 27
New York 24
Bremen 21
Council Bluffs 21
Des Moines 21
Milan 19
Toronto 19
Palermo 17
Houston 16
Jacksonville 16
Rome 16
Ho Chi Minh City 15
Tokyo 15
Buffalo 14
The Dalles 13
Columbus 12
Denver 12
Jyväskylä 12
São Paulo 12
Messina 11
Brooklyn 10
Centro 10
Madrid 10
Phoenix 10
Hanoi 9
Montreal 9
Brno 8
Hong Kong 8
Jakarta 8
Sala Baganza 8
Warsaw 8
Cagliari 7
Florence 7
Hebei 7
London 7
Mascalucia 7
Pozzallo 7
San Francisco 7
Shenyang 7
Wilmington 7
Bari 6
Belo Horizonte 6
Changsha 6
Cotonou 6
Lappeenranta 6
Nanchang 6
Poplar 6
Saint Petersburg 6
Scafati 6
Stockholm 6
Terrassa 6
Brussels 5
Civitavecchia 5
Dong Ket 5
Groningen 5
Guangzhou 5
Johannesburg 5
Orem 5
Raffadali 5
Aci Catena 4
Amsterdam 4
Chennai 4
Curitiba 4
Jiaxing 4
Marseille 4
Pozzo Di Gotto 4
San Giovanni la Punta 4
Santa Maria di Licodia 4
Santiago de Compostela 4
Washington 4
Augusta 3
Bologna 3
Boston 3
Budapest 3
Castelvetrano 3
Dearborn 3
Dhaka 3
Totale 3.415
Nome #
Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors 255
Composti inorganici [Cap. 6] 235
Design, synthesis, and pharmacological evaluation of NO donor-sigma receptors hybrids for the treatment of cancer 157
Combination of heme oxygenase-1 inhibition and sigma receptor modulation for anticancer activity 142
Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis 141
Exploiting the Power of Stereochemistry in Drug Action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as Potent Sigma-1 Receptor Antagonist 128
(+)-Methyl (1R,2S)-2-{[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]methyl}-1-phenylcyclopropanecarboxylate [(+)-MR200] Derivatives as Potent and Selective Sigma Receptor Ligands: Stereochemistry and Pharmacological Properties 124
Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma 124
Novel N-Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists 122
Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform 1 Inhibitors 118
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review 117
Development of Sigma Receptors Nitric Oxide Photodonor Ligands with Antiproliferative Activity 116
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands 111
Design, Synthesis, and Cytotoxic Assessment of New Haloperidol Analogues as Potential Anticancer Compounds Targeting Sigma Receptors 110
Sigma-2 receptor ligands QSAR model dataset 110
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation 110
Cytotoxicity Profiles and Neuroprotective Properties of the Novel Ifenprodil Analogues as Sigma Ligands 109
La modellistica molecolare applicata ai recettori Sigma-1 e Sigma-2: un excursus 106
Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 104
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines 104
Tumor Targeting Sigma Receptor Ligands: Development of New Molecular Hybrids as Anticancer Therapeutics 98
Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands 98
CNS permeability parameters determination through a statistical analysis driven approach 97
New selective Sigma-1/HDACi prodrugs for neurodegenerative disorders 94
Development of NO-releasing sigma receptor hybrids as anticancer agents 94
Novel Sigma-1 receptor antagonists: From opioids to small molecules: What is new? 94
Development of novel H2S-donor sigma receptor hybrids for the management of pain. 93
Correction to Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 91
Discovery of first novel sigma/HDACi dual-ligands with a potent in vitro antiproliferative activity 90
New Insights into the Opioid Analgesic Profile of cis-(-)-N-Normetazocine-derived Ligands 90
Exploring Structural Requirements for Sigma-1 Receptor Linear Ligands: Experimental and Computational Approaches 89
Novel Sigma Receptors Ligands-Nitric Oxide Photodonor: Molecular Hybrids for Double-Targeted Antiproliferative Effect 89
Morphing of ibogaine: A successful attempt into the search for sigma-2 receptor ligands 87
Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation 86
Novel N-normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics in Inflammatory Pain 85
Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis 84
Targeting the hydrophobic heme oxygenase-1 western region for the identification of novel and selective azole-based inhibitors. 83
Design and Synthesis of Tetrahydropyrrolo[3,4‐c]Pyrazole Sigma‐1 Receptor Ligands 81
Synthesis, Computational Insights, and Evaluation of Novel Sigma Receptors Ligands 74
Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents 73
Discovery of AD258 as a Sigma Receptor Ligand with Potent Antiallodynic Activity 71
Repurposing of human kinase inhibitors in neglected protozoan diseases 66
Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents 65
Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H3 and Sigma-1 Receptor Antagonists with Promising Antinociceptive Properties 61
Discovery and computational studies of piperidine/piperazine-based compounds endowed with sigma receptor affinity 61
Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain 60
H2S releasing molecules in pharmaceutical development 58
Sintesi e valutazione preclinica di ligandi per i recettori sigma utili per il trattamento dei tumori e per la gestione del dolore 54
Development of selective sigma-1 receptor ligands with antiallodynic activity: A focus on piperidine and piperazine scaffolds 36
Totale 4.945
Categoria #
all - tutte 15.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.741


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202147 0 0 0 0 0 2 15 1 5 0 10 14
2021/2022320 19 39 26 15 47 4 42 8 23 16 4 77
2022/2023745 69 66 15 107 49 116 8 123 143 9 34 6
2023/2024435 21 58 17 19 37 133 21 19 1 8 70 31
2024/20251.602 55 214 56 125 221 200 201 105 163 82 92 88
2025/20261.385 181 145 442 215 399 3 0 0 0 0 0 0
Totale 4.945